Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 64 articles: HTML format

Single Articles

November 2023
1. GRINSPOON SK, Ribaudo HJ, Douglas PS
   Pitavastatin and Cardiovascular Disease in HIV. Reply.
   N Engl J Med. 2023;389:e46.
   PubMed    
   
   
   
2. OLALLA J, Pombo M
   Pitavastatin and Cardiovascular Disease in HIV.
   N Engl J Med. 2023;389:e46.
   PubMed    
   
   
   
3. IOANNOU P, Filippatos TD, Kofteridis DP
   Pitavastatin and Cardiovascular Disease in HIV.
   N Engl J Med. 2023;389:e46.
   PubMed    
   
   
   
4. ALAM SR, Mureithi M, Ferrand R
   Pitavastatin and Cardiovascular Disease in HIV.
   N Engl J Med. 2023;389:e46.
   PubMed    
   
   
   
5. BOETTIGER DC, Phillips AN, Newall AT
   Pitavastatin and Cardiovascular Disease in HIV.
   N Engl J Med. 2023;389:e46.
   PubMed    
   
   
   October 2023
6. DONOVAN J, Bang ND, Imran D, Nghia HDT, et al
   Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
   N Engl J Med. 2023;389:1357-1367.
   PubMed     Abstract available
   
   
   September 2023
7. ABDOOL KARIM SS, Barre-Sinoussi F, Varmus HE, Serwadda D, et al
   Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization.
   N Engl J Med. 2023;389:1159-1161.
   PubMed    
   
   
   August 2023
8. LO NC, Gonsalves GS
   Outbreaks in U.S. Migrant Detention Centers - A Vaccine-Preventable Cause of Health Inequity.
   N Engl J Med. 2023;389:679-681.
   PubMed    
   
   
   
9. 
   Preventing HIV's Collateral Cardiovascular Damage.
   N Engl J Med. 2023;389:e11.
   PubMed    
   
   
   
10. GODFREY C, Nkengasong J
    Prioritizing Mental Health in the HIV/AIDS Response in Africa.
    N Engl J Med. 2023;389:581-583.
    PubMed    
    
    
    
11. KRAKOWER D, Marcus JL
    Free the PrEP - Over-the-Counter Access to HIV Preexposure Prophylaxis.
    N Engl J Med. 2023 Aug 5. doi: 10.1056/NEJMp2305644.
    PubMed    
    
    
    July 2023
12. GRINSPOON SK, Fitch KV, Zanni MV, Fichtenbaum CJ, et al
    Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
    N Engl J Med. 2023 Jul 23. doi: 10.1056/NEJMoa2304146.
    PubMed     Abstract available
    
    
    
13. FREIBERG MS
    HIV and Cardiovascular Disease - An Ounce of Prevention.
    N Engl J Med. 2023 Jul 23. doi: 10.1056/NEJMe2306782.
    PubMed    
    
    
    
14. NACHEGA JB, Serwadda D, Abimiku A, Sikazwe I, et al
    PEPFAR at 20 - A Game-Changing Impact on HIV in Africa.
    N Engl J Med. 2023;389:1-4.
    PubMed    
    
    
    June 2023
15. OMBAJO LA, Penner J, Nkuranga J, Mecha J, et al
    Second-Line Switch to Dolutegravir for Treatment of HIV Infection.
    N Engl J Med. 2023;388:2349-2359.
    PubMed     Abstract available
    
    
    
16. OGOINA D, James HI
    Mpox among Linked Heterosexual Casual Partners in Bayelsa, Nigeria.
    N Engl J Med. 2023;388:2101-2104.
    PubMed    
    
    
    May 2023
17. DEPUTY NP, Deckert J, Chard AN, Sandberg N, et al
    Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    N Engl J Med. 2023 May 18. doi: 10.1056/NEJMoa2215201.
    PubMed     Abstract available
    
    
    
18. LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
    Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
    N Engl J Med. 2023;388:1680-1691.
    PubMed     Abstract available
    
    
    April 2023
19. LUETKEMEYER AF, Donnell D, Dombrowski JC, Cohen S, et al
    Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
    N Engl J Med. 2023;388:1296-1306.
    PubMed     Abstract available
    
    
    March 2023
20. 
    The Fauci Phenomenon, Part 2.
    N Engl J Med. 2023;388:e40.
    PubMed    
    
    
    
21. 
    The Fauci Phenomenon.
    N Engl J Med. 2023;388:e28.
    PubMed    
    
    
    
22. JOHNSON J, Killelea A, Farrow K
    Investing in National HIV PrEP Preparedness.
    N Engl J Med. 2023;388:769-771.
    PubMed    
    
    
    February 2023
23. PATON NI, Cousins C, Suresh C, Burhan E, et al
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023 Feb 20. doi: 10.1056/NEJMoa2212537.
    PubMed     Abstract available
    
    
    January 2023
24. EKE AC, Mirochnick M, Lockman S
    Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.
    N Engl J Med. 2023;388:344-356.
    PubMed    
    
    
    December 2022
25. NYANG'WA BT, Berry C, Kazounis E, Motta I, et al
    A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2022;387:2331-2343.
    PubMed     Abstract available
    
    
    
26. KIEH M, Richert L, Beavogui AH, Grund B, et al
    Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
    N Engl J Med. 2022 Dec 14. doi: 10.1056/NEJMoa2200072.
    PubMed     Abstract available
    
    
    November 2022
27. AKIYAMA MJ, Spaulding AC, Nijhawan AE
    Long-Acting Injectable Antiretrovirals in Incarcerated Populations - Challenges and Opportunities.
    N Engl J Med. 2022;387:1728-1730.
    PubMed    
    
    
    
28. CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
    Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
    N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
    PubMed     Abstract available
    
    
    September 2022
29. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    PubMed    
    
    
    
30. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    PubMed    
    
    
    
31. CONRADIE F, Bagdasaryan TR, Borisov S, Howell P, et al
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:810-823.
    PubMed     Abstract available
    
    
    
32. PATEL K, Huo Y, Jao J, Powis KM, et al
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med. 2022;387:799-809.
    PubMed     Abstract available
    
    
    August 2022
33. MARCUS JL, Killelea A, Krakower DS
    HIV Prevention and the 340B Drug Pricing Program. Reply.
    N Engl J Med. 2022;387:576.
    PubMed    
    
    
    
34. HALL CS
    HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;387:575-576.
    PubMed    
    
    
    July 2022
35. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    PubMed     Abstract available
    
    
    June 2022
36. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available
    
    
    
37. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    PubMed     Abstract available
    
    
    
38. MARCUS JL, Killelea A, Krakower DS
    Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;386:2064-2066.
    PubMed    
    
    
    May 2022
39. MARRAZZO J
    Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug.
    N Engl J Med. 2022;386:1848-1849.
    PubMed    
    
    
    
40. SEGAL-MAURER S, DeJesus E, Stellbrink HJ, Castagna A, et al
    Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2022;386:1793-1803.
    PubMed     Abstract available
    
    
    
41. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    PubMed    
    
    
    April 2022
42. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    PubMed    
    
    
    March 2022
43. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed     Abstract available
    
    
    
44. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    PubMed    
    
    
    
45. OZELO MC, Mahlangu J, Pasi KJ, Giermasz A, et al
    Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    N Engl J Med. 2022;386:1013-1025.
    PubMed     Abstract available
    
    
    
46. TURKOVA A, Wills GH, Wobudeya E, Chabala C, et al
    Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
    N Engl J Med. 2022;386:911-922.
    PubMed     Abstract available
    
    
    
47. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    PubMed     Abstract available
    
    
    February 2022
48. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    PubMed    
    
    
    January 2022
49. ATMAR RL, Lyke KE, Deming ME, Jackson LA, et al
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMoa2116414.
    PubMed     Abstract available
    
    
    December 2021
50. TURKOVA A, White E, Mujuru HA, Kekitiinwa AR, et al
    Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
    N Engl J Med. 2021;385:2531-2543.
    PubMed     Abstract available
    
    
    
51. COLLIE S, Champion J, Moultrie H, Bekker LG, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119270.
    PubMed    
    
    
    
52. CATTAMANCHI A, Reza TF, Nalugwa T, Adams K, et al
    Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    N Engl J Med. 2021;385:2441-2450.
    PubMed     Abstract available
    
    
    
53. BOR J, Onoya D, Richman B, Mayer KH, et al
    A Failure to Disseminate Transformative Science - HIV Treatment as Prevention, 10 Years On.
    N Engl J Med. 2021;385:2305-2307.
    PubMed    
    
    
    
54. BRAVO MS
    Emperor of the Empire.
    N Engl J Med. 2021;385:2215-2217.
    PubMed    
    
    
    November 2021
55. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    PubMed    
    
    
    October 2021
56. TSENG ZH, Hsue PY, Moffatt E
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. Reply.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
57. OLALLA J, Pombo M
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
58. KLEIN MD, Keen SK, Simpson RJ Jr
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    
    
    
    
59. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed     Abstract available
    
    
    September 2021
60. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment. Reply.
    N Engl J Med. 2021;385:1344.
    PubMed    
    
    
    
61. DE SOCIO GV
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1344.
    PubMed    
    
    
    
62. LEINER S
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1343-1344.
    PubMed    
    
    
    
63. BAYER R, Oppenheimer GM, Parisi V
    Marking the 40th Anniversary of the AIDS Epidemic - American Physicians Look Back.
    N Engl J Med. 2021;385:1251-1253.
    PubMed    
    
    
    
64. GOUVEIA-MORAES F, Campos N
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med. 2021;385:e36.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.